Clinical Trial

Construction of a Multi-dimensional Risk Assessment System: a Clinical Study of Polycystic Ovary Syndrome Complicated With Thrombophilia

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 30, 2026 (before its estimated August 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This observational case-control study aims to develop a multidimensional risk assessment model for thrombophilia-related abnormalities in females with polycystic ovary syndrome (PCOS). The study will analyze endocrine, metabolic, and genetic factors associated with decreased protein C and/or protein S levels in participants with PCOS. The results are expected to provide evidence for risk stratification and individualized management in this population.
Trial Details
NCT Number NCT07571096
Lead Sponsor Guangdong Women and Children Hospital
Conditions Polycystic Ovary Syndrome (PCOS), Thrombophilia
Enrollment 100 participants
Start Date 2025-03-04
Primary Completion 2026-08-01 (estimated)
Study Completion 2027-03-17 (estimated)
Updated on ClinicalTrials.gov 2026-07-30